Zeng-jie Yang
NIH Rank #6853
- R01 Award PI
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11184894Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$1.1M
Full award amounts, FY2026
Award Records
3
Records listing this PI
Award-Linked Rank
#6,853
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Zeng-jie Yang as a PI. Multi-PI records show the full award amount for context.
- 5R01CA290043-02R01Thyroid Hormone Inhibits Medulloblastoma Growth by Inducing Tumor Cell Differentiation$423.5Kaward amount
- 5R01CA276273-04R01Fibroblasts Support the Growth of Brain Metastasis by Rendering Cancer Cells Resistant to Chemotherapy and Inducing Immunosuppression in Tumor Microenvironment$412.5Kaward amount
- 5R21CA296696-02R21Assessment of Efficacy and Toxicity of T3 for Medulloblastoma Treatment$264.2Kaward amount
Award organization
Organizations that administered FY2026 awards listing Zeng-jie Yang as a PI.
FY2026 award administered by Fox Chase Cancer Center (PA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024ScienceDex Coverage BeginsEarliest loaded PI award records: FY2024
- 2025$500K Cumulative Linked Award Amount
- 2025$1M Cumulative Linked Award Amount
- 2025R01 Award Record
- 2026$2M Cumulative Linked Award Amount
- 2026Reached Top 50% by Award-Linked RankRanked #6853